当前位置:首页 - 行情中心 - 雪榕生物(300511) - 财务分析 - 现金流量表

雪榕生物

(300511)

  

流通市值:40.32亿  总市值:46.14亿
流通股本:5.60亿   总股本:6.41亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,315,813,490.16782,645,435.41427,818,796.872,175,962,720.56
  收到的税费返还-1,577.591,577.6-
  收到其他与经营活动有关的现金32,947,291.3230,992,888.169,645,373.3334,262,531.66
  经营活动现金流入小计1,348,760,781.48813,639,901.16437,465,747.82,210,225,252.22
  购买商品、接受劳务支付的现金701,172,110.14424,957,192.19197,895,917.031,180,656,240.6
  支付给职工以及为职工支付的现金335,894,388.41212,788,917.34133,672,809.99496,760,241.16
  支付的各项税费15,733,133.0310,138,502.164,503,655.226,757,758.51
  支付其他与经营活动有关的现金47,804,206.2227,455,080.1215,309,841.8968,849,364.82
  经营活动现金流出小计1,100,603,837.8675,339,691.81351,382,224.111,773,023,605.09
  经营活动产生的现金流量净额248,156,943.68138,300,209.3586,083,523.69437,201,647.13
二、投资活动产生的现金流量:
  收回投资收到的现金4,600,0004,600,0004,600,000-
  处置固定资产、无形资产和其他长期资产收回的现金净额11,887,467.8811,720,097.181,736,242.2318,131,019.57
  投资活动现金流入小计16,487,467.8816,320,097.186,336,242.2318,131,019.57
  购建固定资产、无形资产和其他长期资产支付的现金59,319,655.1626,453,407.1221,139,903.61327,456,793.54
  投资活动现金流出小计59,319,655.1626,453,407.1221,139,903.61327,456,793.54
  投资活动产生的现金流量净额-42,832,187.28-10,133,309.94-14,803,661.38-309,325,773.97
三、筹资活动产生的现金流量:
  吸收投资收到的现金700,000--8,113,754.85
  其中:子公司吸收少数股东投资收到的现金700,000--8,113,754.85
  取得借款收到的现金320,440,000193,590,00069,590,0001,165,446,895.64
  收到其他与筹资活动有关的现金102,000,000102,000,00078,000,00071,645,194.79
  筹资活动现金流入小计423,140,000295,590,000147,590,0001,245,205,845.28
  偿还债务支付的现金588,648,252.9433,582,190.54288,776,399.671,240,198,909.2
  分配股利、利润或偿付利息支付的现金47,098,835.0532,598,884.910,973,913.2667,006,895.16
  支付其他与筹资活动有关的现金37,730,064.3731,234,364.3724,655,875.4274,422,348.28
  筹资活动现金流出小计673,477,152.32497,415,439.81324,406,188.351,381,628,152.64
  筹资活动产生的现金流量净额-250,337,152.32-201,825,439.81-176,816,188.35-136,422,307.36
四、汇率变动对现金及现金等价物的影响39,063.65129,262.32-12,193.2526,728.9
五、现金及现金等价物净增加额-44,973,332.27-73,529,278.08-105,548,519.24-8,019,705.3
  加:期初现金及现金等价物余额149,941,516.62149,941,516.62149,941,516.62157,961,221.92
  期末现金及现金等价物余额104,968,184.3576,412,238.5444,392,997.38149,941,516.62
补充资料:
  净利润--97,273,595.86--616,406,262.2
  资产减值准备--617,599.52-426,191,974.36
  固定资产和投资性房地产折旧-169,902,123.38-361,858,138.86
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-169,902,123.38-361,858,138.86
  无形资产摊销-3,948,172.77-8,299,590.72
  长期待摊费用摊销-1,532,985.83-5,133,059.9
  处置固定资产、无形资产和其他长期资产的损失-12,375,039.33--7,850,323.36
  固定资产报废损失-449,324.37-2,460,785.09
  公允价值变动损失---645,524.3
  财务费用-35,326,614.88-97,156,153.41
  投资损失--1,013,061.49--
  存货的减少--16,885,419-73,989,070.84
  经营性应收项目的减少-1,755,107-11,801,926.38
  经营性应付项目的增加-49,569,951.35-70,162,040.53
  其他--21,303,171.01--
  现金的期末余额-76,412,238.54-149,941,516.62
  减:现金的期初余额-149,941,516.62-157,961,221.92
  现金及现金等价物的净增加额--73,529,278.08--8,019,705.3
公告日期2025-10-162025-08-272025-04-282025-04-28
审计意见(境内)标准无保留意见
TOP↑